Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Moore

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Diabetes Research and Clinical Practice|February 21, 2012
Clinical assessment of HNF1A and GCK variants and identification of a novel mutation causing MODY2Ashley H Shoemaker, Jozef Zienkiewicz, Daniel J Moore
Frontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Regulatory CD4+CD25+T cells in prevention of allograft rejectionMajor K Lee, Daniel J Moore, James F Markmann
Diabetes Care|October 27, 2023
Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013William E Russell, Daniel J Moore, Kevan C Herold
Current Opinion in Endocrinology, Diabetes, and Obesity|February 24, 2012
Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetesJoann Romano-Keeler, Jöern-Hendrik Weitkamp, Daniel J Moore
AJR. American Journal of Roentgenology|October 26, 2005
Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of diseaseGregory E Wilde, Daniel J Moore, Richard D Bellah
Plos One|August 30, 2014
Dysregulation of T lymphocyte proliferative responses in autoimmunitySydney K Elizer, Andrew F Marshall, Daniel J Moore
Diabetes|April 22, 2020
The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 DiabetesJustin M Gregory, Alan D Cherrington, Daniel J Moore
Pediatrics in Review|May 3, 2013
Type 1 diabetes mellitusJustin M Gregory, Daniel J Moore, Jill H Simmons
Leukemia & Lymphoma|March 25, 2020
Pembrolizumab immunotherapy for relapsed CNS LymphomaJerome J Graber, Benjamin Plato, Raya Mawad, et al.
Current Medical Research and Opinion|December 21, 2024
Understanding the different stages of type 1 diabetes and their management: a plain language summaryDaniel J Moore, Natasha I Leibel, William Polonsky, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Diabetes Research and Clinical Practice|February 21, 2012
Clinical assessment of HNF1A and GCK variants and identification of a novel mutation causing MODY2Ashley H Shoemaker, Jozef Zienkiewicz, Daniel J Moore
Frontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Regulatory CD4+CD25+T cells in prevention of allograft rejectionMajor K Lee, Daniel J Moore, James F Markmann
Diabetes Care|October 27, 2023
Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013William E Russell, Daniel J Moore, Kevan C Herold
Current Opinion in Endocrinology, Diabetes, and Obesity|February 24, 2012
Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetesJoann Romano-Keeler, Jöern-Hendrik Weitkamp, Daniel J Moore
AJR. American Journal of Roentgenology|October 26, 2005
Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of diseaseGregory E Wilde, Daniel J Moore, Richard D Bellah
Plos One|August 30, 2014
Dysregulation of T lymphocyte proliferative responses in autoimmunitySydney K Elizer, Andrew F Marshall, Daniel J Moore
Diabetes|April 22, 2020
The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 DiabetesJustin M Gregory, Alan D Cherrington, Daniel J Moore
Pediatrics in Review|May 3, 2013
Type 1 diabetes mellitusJustin M Gregory, Daniel J Moore, Jill H Simmons
Leukemia & Lymphoma|March 25, 2020
Pembrolizumab immunotherapy for relapsed CNS LymphomaJerome J Graber, Benjamin Plato, Raya Mawad, et al.
Current Medical Research and Opinion|December 21, 2024
Understanding the different stages of type 1 diabetes and their management: a plain language summaryDaniel J Moore, Natasha I Leibel, William Polonsky, et al.
Pageof 11